Condition: Paroxysmal Atrial Fibrillation · Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Observational, multi-center, non-randomized, post-market study. This is a nested sub-study of the REAL AF Registry. Consecutive symptomatic drug refractory paroxysmal atrial fibrillation (PAF) patients from the registry will be screened for enrollment, prospectively or retrospectively, to this sub-study per inclusion and exclusion criteria.
This description comes directly from the study's public registry record.
Jennifer Moss · 615-448-5770 · jmoss@hrcrs.com
Always discuss trial participation with your own doctor first.
| Arrhythmia Institute at Grandview | Birmingham, Alabama, United States | Recruiting |
| Mobile Cardiology Associates | Mobile, Alabama, United States | Recruiting |
| Community Memorial Health System | Ventura, California, United States | Recruiting |
| Medical City - HCA | Aurora, Colorado, United States | Recruiting |
| Naples Community Hospital | Naples, Florida, United States | Withdrawn |
| Sarasota Memorial Health | Sarasota, Florida, United States | Recruiting |
| Piedmont Healthcare | Atlanta, Georgia, United States | Recruiting |
| Norton Heart and Vascular Institute | Louisville, Kentucky, United States | Recruiting |
| The Brigham and Womens Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| Sparrow Clinical Research Institute | Lansing, Michigan, United States | Recruiting |
| Trinity Health-Michigan Heart | Ypsilanti, Michigan, United States | Recruiting |
| The Christ Hospital | Cincinnati, Ohio, United States | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06324201